177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
Active, not recruiting · NCT00859781 · Registry updated 2026-04-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2026-04-08 | NCT00859781 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| United States Department of Defense | 319 |
| Weill Medical College of Cornell University | 276 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars Sinai | Los Angeles | United States | 21 |
| Georgetown University Medical Center | Washington D.C. | United States | 62 |
| Indiana University Melvin and Bren Simon Cancer Center | Indianapolis | United States | 17 |
| The University of Kansas Cancer Center | Westwood | United States | 31 |
| University of Iowa Hospitals and Clinics | Iowa City | United States | 99 |
| University of Utah | Salt Lake City | United States | 72 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |
| USC/Norris Comprehensive cancer center | Los Angeles | United States | 1 |
| Weill Cornell Medical College | New York | United States | 35 |